PLEKHF1 and prostate carcinoma: In addition, aPPD is a strong promoter of apoptosis in C4-2 androgen-dependent prostate cancer cells as well as in LNCaP androgen dependent cells in vitro, and in PC-3 androgen-independent prostate cancer xenografts in vivo [2, 12, 18, 19].